Cutting Through The Confusion On US Biosimilar Interchangeability
Experts Offer Clarity Amid Misunderstandings Over US FDA Designation
• By David Wallace
Confusion remains over aspects of the US FDA interchangeability designation • Source: Shutterstock 
